コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n upon miR-200 overexpression toward that of highly metastatic cells.
2 elta levels were relatively increased in the highly metastatic cells.
3 transcripts displaying reduced stability in highly metastatic cells.
4 gainst poorly metastatic cells compared with highly metastatic cells.
5 ignificantly impairs the bone progression of highly metastatic cells.
6 s phosphoinositide 3-kinase, AKT, and SRC in highly metastatic cells.
7 g ligand activation of the EGFR, but only in highly-metastatic cells.
8 ecause they preferentially activate c-Src in highly-metastatic cells.
10 ere we show that loss of c-KIT expression in highly metastatic cells correlates with loss of expressi
11 at up-regulation of MCAM/MUC18 expression in highly metastatic cells correlates with loss of expressi
12 etastatic variants, suggest that not only do highly-metastatic cells display constitutively elevated
13 ration of miR-10b antagomirs to mice bearing highly metastatic cells does not reduce primary mammary
15 ompared with poorly metastatic cancer cells, highly metastatic cells expressed increased levels of th
18 usly shown that enforced c-KIT expression in highly metastatic cells inhibited tumor growth and metas
20 y a poorly metastatic cell line to that by a highly metastatic cell line 24 h after injection in the
21 -2 mRNA stabilization in MDA-MB-231 cells, a highly metastatic cell line derived from a human mammary
22 ential reversal of oncogenic properties of a highly metastatic cell line with the introduction of non
23 ially expressed (greater than 2-fold) in all highly metastatic cell lines relative to their reference
32 kinase expression was first demonstrated in highly metastatic cells, whilst re-expression of the pro
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。